Register Login
Register to leave comments
  • News bot March 12, 2026, 8:13 p.m.

    📋 VAXART, INC. (VXRT) - Financial Results

    Filing Date: 2026-03-12

    Accepted: 2026-03-12 16:11:47

    Event Type: Financial Results

    Event Details:

    VAXART, INC. (VXRT) Reports the reporting period Financial Results VAXART, INC. (VXRT) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 237258
    • Net Income: 230346201
    • EPS: Not disclosed
    • Cash and equivalents: 53814
      • 19 Vaccine Developments ● As previously announced, Vaxart completed enrollment of approximately 5,400 participants for the COVID
      • 19 Phase 2b trial, comprised of 400 participants in the sentinel cohort and approximately 5,000 participants in the KP.2 cohort comparing the Company’s oral pill vaccine with a commercially available mRNA COVID
      • 19 vaccine. The study is proceeding as planned, with participants monitored for up to 12 months post
        • anticipated in the fourth quarter of 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Assets Prepaid Expenses Other Current Assets 21.51K 5.41K $16.10K +297.82%
    Assets Property Equipment Net 5.43K 8.71K $-3.27K -37.59%
    Assets Intangible Assets Net 2.83K 3.56K $-731.00 -20.55%
    Liabilities And Stockholdersequity Accounts Payable 21.50K 6.96K $14.53K +208.72%
    Liabilities And Stockholdersequity Operating Lease Liabilities 8.98K 17.53K $-8.54K -48.73%
    Revenue 237.26K 28.70K $208.56K +726.68%
    Operating Expenses Net Loss Per Share 0.07 0.33 $-0.26 -78.79%
    Other Assets 21.51K 5.41K $16.10K +297.82%
    Property and Equipment, Net 5.43K 8.71K $-3.27K -37.59%
    Intangible Assets, Net 2.83K 3.56K $-731.00 -20.55%
    Accounts Payable 21.50K 6.96K $14.53K +208.72%
    Revenue 68.00 65.40K $-65.33K -99.90%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: VAXART, INC.
    • Ticker Symbol: VXRT

Search

News categories